244 related articles for article (PubMed ID: 27870591)
21. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice.
Hart MK; Pratt W; Panelo F; Tammariello R; Dertzbaugh M
Vaccine; 1997 Mar; 15(4):363-9. PubMed ID: 9141206
[TBL] [Abstract][Full Text] [Related]
22. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE
Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821
[TBL] [Abstract][Full Text] [Related]
23. Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.
Braid LR; Hu WG; Davies JE; Nagata LP
Stem Cells Transl Med; 2016 Aug; 5(8):1026-35. PubMed ID: 27334491
[TBL] [Abstract][Full Text] [Related]
24. [The vaccines based on the replicon of the venezuelan equine encephalomyelitis virus against viral hemorrhagic fevers].
Petrov AA; Plekhanova TM; Sidorova ON; Borisevich SV; Makhlay AA
Vopr Virusol; 2015; 60(3):14-8. PubMed ID: 26281301
[TBL] [Abstract][Full Text] [Related]
25. IRES-Containing VEEV Vaccine Protects Cynomolgus Macaques from IE Venezuelan Equine Encephalitis Virus Aerosol Challenge.
Rossi SL; Russell-Lodrigue KE; Killeen SZ; Wang E; Leal G; Bergren NA; Vinet-Oliphant H; Weaver SC; Roy CJ
PLoS Negl Trop Dis; 2015 May; 9(5):e0003797. PubMed ID: 26020513
[TBL] [Abstract][Full Text] [Related]
26. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
[TBL] [Abstract][Full Text] [Related]
27. Designing multivalent immunogens for alphavirus vaccine optimization.
Read CM; Plante K; Rafael G; Rossi SL; Braun W; Weaver SC; Schein CH
Virology; 2021 Sep; 561():117-124. PubMed ID: 33823988
[TBL] [Abstract][Full Text] [Related]
28. An immunological profile of Balb/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccine.
Bennett AM; Elvin SJ; Wright AJ; Jones SM; Phillpotts RJ
Vaccine; 2000 Sep; 19(2-3):337-47. PubMed ID: 10930689
[TBL] [Abstract][Full Text] [Related]
29. [The duration of humoral postvaccinal and postinfection immunity to the Venezuelan equine encephalomyelitis virus].
Lukin EP; Chernikova NK
Vopr Virusol; 1993; 38(2):71-4. PubMed ID: 8059525
[TBL] [Abstract][Full Text] [Related]
30. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies.
Rosas CT; Paessler S; Ni H; Osterrieder N
Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789
[TBL] [Abstract][Full Text] [Related]
31. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
32. [The protective activity of the attenuated strain 15 of the Venezuelan equine encephalomyelitis virus in rodent infection via the respiratory tract].
Filatenkov AG; Khaltaeva GG; Khlebnikova NN; Gorban' SG; Shkurnikova NN; Khamitova MF
Vopr Virusol; 1991; 36(3):229-31. PubMed ID: 1891877
[TBL] [Abstract][Full Text] [Related]
33. A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates.
Dupuy LC; Richards MJ; Ellefsen B; Chau L; Luxembourg A; Hannaman D; Livingston BD; Schmaljohn CS
Clin Vaccine Immunol; 2011 May; 18(5):707-16. PubMed ID: 21450977
[TBL] [Abstract][Full Text] [Related]
34. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate.
Hart MK; Caswell-Stephan K; Bakken R; Tammariello R; Pratt W; Davis N; Johnston RE; Smith J; Steele K
Vaccine; 2000 Jul; 18(26):3067-75. PubMed ID: 10825611
[TBL] [Abstract][Full Text] [Related]
35. [The postvaccinal reaction in hamadryas baboons to the administration of attenuated strain 15 of the Venezuelan equine encephalomyelitis virus].
Filatenkov AG; Khaltaeva GG; Lukin EP; Gorban' SG; Khamitova MF; Shkurnikova NN
Biull Eksp Biol Med; 1991 Mar; 111(3):287-90. PubMed ID: 2054507
[TBL] [Abstract][Full Text] [Related]
36. The transcriptional landscape of Venezuelan equine encephalitis virus (TC-83) infection.
Yao Z; Zanini F; Kumar S; Karim M; Saul S; Bhalla N; Panpradist N; Muniz A; Narayanan A; Quake SR; Einav S
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009306. PubMed ID: 33788849
[TBL] [Abstract][Full Text] [Related]
37. Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development.
Sharma A; Knollmann-Ritschel B
Viruses; 2019 Feb; 11(2):. PubMed ID: 30781656
[TBL] [Abstract][Full Text] [Related]
38. Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challenge.
Tretyakova I; Plante KS; Rossi SL; Lawrence WS; Peel JE; Gudjohnsen S; Wang E; Mirchandani D; Tibbens A; Lamichhane TN; Lukashevich IS; Comer JE; Weaver SC; Pushko P
Vaccine; 2020 Apr; 38(17):3378-3386. PubMed ID: 32085953
[TBL] [Abstract][Full Text] [Related]
39. Immunologic interference from sequential administration of live attenuated alphavirus vaccines.
McClain DJ; Pittman PR; Ramsburg HH; Nelson GO; Rossi CA; Mangiafico JA; Schmaljohn AL; Malinoski FJ
J Infect Dis; 1998 Mar; 177(3):634-41. PubMed ID: 9498442
[TBL] [Abstract][Full Text] [Related]
40. A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation.
Hannaman D; Dupuy LC; Ellefsen B; Schmaljohn CS
Vaccine; 2016 Jun; 34(31):3607-12. PubMed ID: 27206386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
